Literature DB >> 23505027

PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability.

Yanfeng Liu1, Ju-Bo Zhang, Yi Qin, Wei Wang, Lili Wei, Yigang Teng, Lei Guo, Bo Zhang, Zhenhai Lin, Jing Liu, Zheng-Gang Ren, Qing-Hai Ye, Youhua Xie.   

Abstract

UNLABELLED: Hepatocellular carcinoma (HCC) is one of the most common cancers and the third leading cause of death from cancer worldwide. HCC has a very poor prognosis because of tumor invasiveness, frequent intrahepatic spread, and extrahepatic metastasis. The molecular mechanism of HCC invasiveness and metastasis is poorly understood. The homeobox protein PROX1 is required for hepatocyte migration during mouse embryonic liver development. In this study, we show that high PROX1 protein expression in primary HCC tissues is associated with significantly worse survival and early tumor recurrence in postoperative HCC patients. Knockdown of PROX1 expression in HCC cells inhibited cell migration and invasiveness in vitro and HCC metastasis in nude mice while overexpression of PROX1 in HCC cells promoted these processes. PROX1's pro-metastasis activity is most likely attributed to its up-regulation of hypoxia-inducible factor 1α (HIF-1α) transcription and stabilization of HIF-1α protein by recruiting histone deacetylase 1 (HDAC1) to prevent the acetylation of HIF-1α, which subsequently induces an epithelial-mesenchymal transition response in HCC cells. We further demonstrated the prognostic value of using the combination of PROX1 and HDAC1 levels to predict postoperative survival and early recurrence of HCC.
CONCLUSION: PROX1 is a critical factor that promotes HCC metastasis.
Copyright © 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23505027     DOI: 10.1002/hep.26398

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

1.  Prox1 inhibits neurite outgrowth during central nervous system development.

Authors:  Valeria Kaltezioti; Iosifina P Foskolou; Matthieu D Lavigne; Elpinickie Ninou; Matina Tsampoula; Maria Fousteri; Marigoula Margarity; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2020-11-28       Impact factor: 9.261

2.  PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.

Authors:  Y Liu; X Ye; J-B Zhang; H Ouyang; Z Shen; Y Wu; W Wang; J Wu; S Tao; X Yang; K Qiao; J Zhang; J Liu; Q Fu; Y Xie
Journal:  Oncogene       Date:  2015-02-16       Impact factor: 9.867

3.  MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma.

Authors:  Lei Yu; Luting Zhou; Yu Cheng; Lei Sun; Jian Fan; Jinlong Liang; Mujie Guo; Ning Liu; Liying Zhu
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

4.  Epigenetically silenced long noncoding-SRHC promotes proliferation of hepatocellular carcinoma.

Authors:  Hao Zheng; Sen Yang; Yuan Yang; Sheng-Xian Yuan; Fu-Quan Wu; Li-Li Wang; Hong-Li Yan; Shu-Han Sun; Wei-Ping Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-16       Impact factor: 4.553

Review 5.  The impact of hypoxia in hepatocellular carcinoma metastasis.

Authors:  Carmen Chak-Lui Wong; Alan Ka-Lun Kai; Irene Oi-Lin Ng
Journal:  Front Med       Date:  2013-11-14       Impact factor: 4.592

6.  Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.

Authors:  Xianfu Sun; Tao Huang; Chengjuan Zhang; Shengze Zhang; Yingjie Wang; Qiang Zhang; Zhenzhen Liu
Journal:  Cell Cycle       Date:  2019-06-29       Impact factor: 5.173

7.  Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct Carcinoma.

Authors:  Ping Wang; Yu He; Xiaodong Ma; Beiwang Sun; Binyuan Huang; Canhua Zhu; Yanmin Liu
Journal:  Med Sci Monit       Date:  2015-10-01

8.  Impact of an altered PROX1 expression on clinicopathology, prognosis and progression in renal cell carcinoma.

Authors:  Tao Lv; Yanfeng Liu; Jianping Zhang; Le Xu; Yu Zhu; Hankun Yin; Huimin An; Zongming Lin; Youhua Xie; Lian Chen
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

9.  MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1.

Authors:  Ying Liu; Yi Ding; Jing Huang; Shuang Wang; Wen Ni; Jian Guan; Qisheng Li; Yuqin Zhang; Yanqing Ding; Bin Chen; Longhua Chen
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

10.  The association of transcription factor Prox1 with the proliferation, migration, and invasion of lung cancer.

Authors:  Xinxin Hao; Wenting Luo; Xueshan Qiu
Journal:  Open Life Sci       Date:  2021-06-19       Impact factor: 0.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.